Core Scientific, Inc.
CORZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,715,002 | $5,428,004 | $2,281,947 | $4,301,351 |
| - Cash | $453,443 | $581,345 | $697,942 | $836,197 |
| + Debt | $1,059,007 | $1,160,910 | $1,194,153 | $1,199,769 |
| Enterprise Value | $6,320,566 | $6,007,569 | $2,778,158 | $4,664,923 |
| Revenue | $81,103 | $78,628 | $79,525 | $94,925 |
| % Growth | 3.1% | -1.1% | -16.2% | – |
| Gross Profit | $3,776 | $5,025 | $8,213 | $4,763 |
| % Margin | 4.7% | 6.4% | 10.3% | 5% |
| EBITDA | -$127,462 | -$634 | -$20,183 | -$234,875 |
| % Margin | -157.2% | -0.8% | -25.4% | -247.4% |
| Net Income | -$146,660 | -$936,799 | $580,693 | -$265,541 |
| % Margin | -180.8% | -1,191.4% | 730.2% | -279.7% |
| EPS Diluted | -0.46 | -0.042 | 1.25 | -0.6 |
| % Growth | -1,003.1% | -103.3% | 308.3% | – |
| Operating Cash Flow | $131,781 | $34,000 | -$40,599 | $13,805 |
| Capital Expenditures | -$254,617 | -$121,279 | -$88,422 | -$28,758 |
| Free Cash Flow | -$122,836 | -$87,279 | -$129,021 | -$14,953 |